NSE · ASTEC
Astec Lifesciences Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹72 Cr with net profit ₹-37 Cr — a -51.97% net margin, versus -22.43% the period before.
Shareholding
As of 2026-09-30
- Promoter71.96%
- Public24.67%
- FII0.03%
- DII3.34%
19,707 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.83× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pesticides / Agrochemicals - Indian · ranked #13 of 30 by market cap · medians across 26 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| UPL Limited | ₹45,140 Cr | 23.47 | 1.3 | 5.42% | 3.59% |
| PI Industries Ltd. | ₹26,323 Cr | 33.19 | 2.3 | 7.66% | 13.84% |
| Sumitomo Chemical India Ltd. | ₹16,419 Cr | 29.8 | 4.44 | 15.12% | 17.35% |
| Sharda Cropchem Ltd. | ₹6,186 Cr | 9.61 | 1.9 | 19.8% | 11.75% |
| Dhanuka Agritech Ltd. | ₹4,055 Cr | 14.12 | 2.41 | 24.54% | 13.13% |
| Rallis India Ltd. | ₹3,684 Cr | 17.94 | 1.68 | 8.99% | 6.66% |
| NACL Industries Limited | ₹2,746 Cr | 105.59 | 4.03 | 1.2% | 0.58% |
| Bhagiradha Chemicals & Industries Ltd. | ₹2,549 Cr | 92.71 | 3.55 | 3.83% | 4.31% |
| Bharat Rasayan Ltd. | ₹1,613 Cr | 11.03 | 1.26 | 11.43% | 11.92% |
| Insecticides India Ltd. | ₹1,586 Cr | 12.67 | 1.2 | 9.26% | 5.8% |
| Astec Lifesciences Ltd.(this company) | ₹1,248 Cr | — | 3.73 | -23.77% | -18.13% |
AI analysis
AI-generated · google/gemini-2.5-flashAstec Lifesciences Ltd. is listed with a market capitalization of Rs 1561 Cr. The company reported revenue of Rs 386.93 Cr and an EPS of -68.74. Its book value is Rs 119.36 per share.
Positives
- +Promoter holding is high at 71.97% as of March 31, 2026.
- +No promoter shares are reported as pledged.
Negatives
- −The company has negative earnings per share (EPS) of -68.74.
- −The Return on Equity (ROE) is negative at -44.7%.
- −The Return on Capital Employed (ROCE) is negative at -5.54%.
- −The debt-to-equity ratio is high at 1.74.
- −The company reported a net profit of -7.76 Cr for Mar 2026.
Financial Performance
Astec Lifesciences Ltd. reported a revenue of Rs 386.93 Cr. The company's EPS stands at -68.74. Quarterly results show a revenue of Rs 158.62 Cr for Mar 2026, with a net profit of -7.76 Cr. In the preceding quarter, Dec 2025, revenue was Rs 124.72 Cr and net profit was -15.7 Cr.
Profitability & Returns
The company's Return on Equity (ROE) is -44.7% and Return on Capital Employed (ROCE) is -5.54%. The EPS for the latest period is -68.74. The company has not provided a dividend yield.
Balance Sheet
Astec Lifesciences Ltd. has a debt-to-equity ratio of 1.74. The book value per share is Rs 119.36. The company's market capitalization is Rs 1561 Cr.
Ownership & Pledges
The company has reported no promoter share pledges.
Regulatory & Surveillance
No information regarding surveillance measures has been provided for Astec Lifesciences Ltd. for the reporting period.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.